These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10624116)
1. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations. Tomaszewska R; Nowak K; Stachura J Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116 [TBL] [Abstract][Full Text] [Related]
2. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma]. Tomaszewska R Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas. Satoh K; Shimosegawa T; Koizumi M; Toyota T Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654 [TBL] [Abstract][Full Text] [Related]
4. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860 [TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
6. Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival. Sessa F; Bonato M; Bisoni D; Ranzani GN; Capella C Eur J Histochem; 1998; 42 Spec No():67-76. PubMed ID: 10076772 [TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up. Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431 [TBL] [Abstract][Full Text] [Related]
8. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions. Hermanova M; Trna J; Nenutil R; Dite P; Kala Z Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777 [TBL] [Abstract][Full Text] [Related]
9. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53. Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265 [TBL] [Abstract][Full Text] [Related]
10. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas. Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947 [TBL] [Abstract][Full Text] [Related]
12. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385 [TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features. Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545 [TBL] [Abstract][Full Text] [Related]
15. Reduced expression of p53 and cyclin A in intraductal mucin-hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma. Mukawa K; Kawa S; Aoki Y; Zhai Y; Nikaido T Am J Gastroenterol; 1999 Aug; 94(8):2263-7. PubMed ID: 10445560 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Yamasawa K; Nio Y; Dong M; Yamaguchi K; Itakura M Clin Cancer Res; 2002 Aug; 8(8):2563-9. PubMed ID: 12171884 [TBL] [Abstract][Full Text] [Related]
17. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage? Regauer S; Ott A; Berghold A; Beham A J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression. Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431 [TBL] [Abstract][Full Text] [Related]
19. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. Wada K J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900 [TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53]. Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]